219 related articles for article (PubMed ID: 37157842)
1. Mean platelet volume: a prognostic marker in heart failure with preserved ejection fraction.
Menghoum N; Beauloye C; Lejeune S; Badii MC; Gruson D; van Dievoet MA; Pasquet A; Vancraeynest D; Gerber B; Bertrand L; Horman S; Pouleur AC
Platelets; 2023 Dec; 34(1):2188965. PubMed ID: 37157842
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction.
Roy C; Lejeune S; Slimani A; de Meester C; Ahn As SA; Rousseau MF; Mihaela A; Ginion A; Ferracin B; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Horman S; Gruson D; Gerber BL; Pouleur AC
ESC Heart Fail; 2020 Oct; 7(5):2494-2507. PubMed ID: 32578967
[TBL] [Abstract][Full Text] [Related]
3. Diabetic phenotype and prognosis of patients with heart failure and preserved ejection fraction in a real life cohort.
Lejeune S; Roy C; Slimani A; Pasquet A; Vancraeynest D; Vanoverschelde JL; Gerber BL; Beauloye C; Pouleur AC
Cardiovasc Diabetol; 2021 Feb; 20(1):48. PubMed ID: 33608002
[TBL] [Abstract][Full Text] [Related]
4. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
5. Prognostic benefit of early diagnosis with exercise stress testing in heart failure with preserved ejection fraction.
Saito Y; Obokata M; Harada T; Kagami K; Wada N; Okumura Y; Ishii H
Eur J Prev Cardiol; 2023 Jul; 30(9):902-911. PubMed ID: 37094815
[TBL] [Abstract][Full Text] [Related]
6. The impact of platelet indices on clinical outcome in heart failure: results from the MyoVasc study.
Dahlen B; Schulz A; Göbel S; Tröbs SO; Schwuchow-Thonke S; Spronk HM; Prochaska JH; Arnold N; Lackner KJ; Gori T; Ten Cate H; Münzel T; Wild PS; Panova-Noeva M
ESC Heart Fail; 2021 Aug; 8(4):2991-3001. PubMed ID: 33939298
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015
[TBL] [Abstract][Full Text] [Related]
8. Carbohydrate antigen 125: a useful marker of congestion, fibrosis, and prognosis in heart failure with preserved ejection fraction.
Menghoum N; Badii MC; Deltombe M; Lejeune S; Roy C; Vancraeynest D; Pasquet A; Gerber BL; Horman S; Gruson D; Beauloye C; Pouleur AC
ESC Heart Fail; 2024 Jun; 11(3):1493-1505. PubMed ID: 38339764
[TBL] [Abstract][Full Text] [Related]
9. Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction.
Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
Int J Cardiovasc Imaging; 2020 May; 36(5):921-928. PubMed ID: 32030576
[TBL] [Abstract][Full Text] [Related]
10. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
[TBL] [Abstract][Full Text] [Related]
11. High-Sensitivity C-Reactive Protein Is Associated With Heart Failure Hospitalization in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease and Normal Left Ventricular Ejection Fraction Undergoing Coronary Angiography.
Zhou XD; Chen QF; Targher G; Byrne CD; Shapiro MD; Tian N; Xiao T; Sung KC; Lip GYH; Zheng MH
J Am Heart Assoc; 2024 Feb; 13(3):e032997. PubMed ID: 38240197
[TBL] [Abstract][Full Text] [Related]
12. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
[TBL] [Abstract][Full Text] [Related]
13. Right Ventricular Global Longitudinal Strain and Outcomes in Heart Failure with Preserved Ejection Fraction.
Lejeune S; Roy C; Ciocea V; Slimani A; de Meester C; Amzulescu M; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Gerber BL; Pouleur AC
J Am Soc Echocardiogr; 2020 Aug; 33(8):973-984.e2. PubMed ID: 32387031
[TBL] [Abstract][Full Text] [Related]
14. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
Kontogeorgos S; Thunström E; Johansson MC; Fu M
Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
[TBL] [Abstract][Full Text] [Related]
15. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
[TBL] [Abstract][Full Text] [Related]
16. Associations and prognostic significance of diffuse myocardial fibrosis by cardiovascular magnetic resonance in heart failure with preserved ejection fraction.
Roy C; Slimani A; de Meester C; Amzulescu M; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Gerber BL; Pouleur AC
J Cardiovasc Magn Reson; 2018 Aug; 20(1):55. PubMed ID: 30086783
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
[No Abstract] [Full Text] [Related]
18. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
[No Abstract] [Full Text] [Related]
19. Biomarker-driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
Pocock SJ; Ferreira JP; Packer M; Zannad F; Filippatos G; Kondo T; McMurray JJV; Solomon SD; Januzzi JL; Iwata T; Salsali A; Butler J; Anker SD
Eur J Heart Fail; 2022 Oct; 24(10):1869-1878. PubMed ID: 35796209
[TBL] [Abstract][Full Text] [Related]
20. Modified Glasgow Prognostic Score is a novel predictor of clinical outcome in heart failure with preserved ejection fraction.
Bolat I; Biteker M
Scand Cardiovasc J; 2020 Jun; 54(3):174-178. PubMed ID: 31965867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
